Carboplatin - Generic Drug Details

✉ Email this page to a colleague

What are the generic sources for carboplatin and what is the scope of patent protection?

Carboplatin is the generic ingredient in two branded drugs marketed by Cipla Ltd, Fresenius Kabi Usa, Hikma, Hospira, Natco Pharma Usa, Pliva, Sandoz, Watson Labs Teva, Corden Pharma, Accord Hlthcare, Actavis Totowa, Epic Pharma Llc, Eugia Pharma, Gland Pharma Ltd, Meitheal, Norvium Bioscience, Novast Labs, Pharmachemie Bv, Pliva Lachema, Sun Pharm, Teva Parenteral, Teva Pharms Usa, Teyro Labs, and Cordenpharma, and is included in thirty-five NDAs. Additional information is available in the individual branded drug profile pages.

There are eighteen drug master file entries for carboplatin. Eleven suppliers are listed for this compound.

Summary for carboplatin

US Patents:	0
Tradenames:	2
Applicants:	24
NDAs:	35
Drug Master File Entries:	18
Finished Product Suppliers / Packagers:	11
Raw Ingredient (Bulk) Api Vendors:	31
Clinical Trials:	2,994
Patent Applications:	265
Drug Prices:	Drug price trends for carboplatin
What excipients (inactive ingredients) are in carboplatin?	carboplatin excipients list
DailyMed Link:	carboplatin at DailyMed

See drug prices for carboplatin

Recent Clinical Trials for carboplatin

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
EMD Serono	Phase 1
Istituto Oncologico Veneto IRCCS	Phase 2
Yale University	Phase 1

See all carboplatin clinical trials

Pharmacology for carboplatin

Drug Class	Platinum-based Drug

Medical Subject Heading (MeSH) Categories for carboplatin

Antineoplastic Agents
Cross-Linking Reagents

Anatomical Therapeutic Chemical (ATC) Classes for carboplatin

L01XA	Platinum compounds
L01X	OTHER ANTINEOPLASTIC AGENTS
L01	ANTINEOPLASTIC AGENTS
L	Antineoplastic and immunomodulating agents

US Patents and Regulatory Information for carboplatin

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Norvium Bioscience	CARBOPLATIN	carboplatin	INJECTABLE;INTRAVENOUS	091063-004	Nov 9, 2011		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Natco Pharma Usa	CARBOPLATIN	carboplatin	INJECTABLE;INJECTION	091510-002	May 29, 2012		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Pliva	CARBOPLATIN	carboplatin	INJECTABLE;INJECTION	076602-001	Nov 16, 2004		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Actavis Totowa	CARBOPLATIN	carboplatin	INJECTABLE;INTRAVENOUS	078732-001	Feb 6, 2012		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for carboplatin

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Cordenpharma	PARAPLATIN	carboplatin	INJECTABLE;INTRAVENOUS	020452-001	Jul 14, 2003	⤷ Sign Up	⤷ Sign Up
Corden Pharma	PARAPLATIN	carboplatin	INJECTABLE;INJECTION	019880-001	Mar 3, 1989	⤷ Sign Up	⤷ Sign Up
Corden Pharma	PARAPLATIN	carboplatin	INJECTABLE;INJECTION	019880-003	Mar 3, 1989	⤷ Sign Up	⤷ Sign Up
Cordenpharma	PARAPLATIN	carboplatin	INJECTABLE;INTRAVENOUS	020452-003	Jul 14, 2003	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.